Calcitonin gene-related peptide - Akela Pharma
Alternative Names: Akela CGRP; CGRP - Akela Pharma; LAB CGRPLatest Information Update: 02 Oct 2021
At a glance
- Originator University of Sherbrooke
- Developer Akela Pharma
- Class Antiarrhythmics; Antiasthmatics; Neuropeptides; Vasodilators
- Mechanism of Action Calcitonin gene-related peptide agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma